Immunowake raises $3M in Financing

Birmingham, AL - 22nd August 2019. Immunowake has raised $3M in financing, led by Changchun High-tech Industries Group Inc (SZSE: 000661). This investment will be used to accelerate the research, development, and commercialization of Immunowake’s portfolio.

Immunowake is a pre-clinical company focused on the development of antibody-based therapeutics against cancer. Immunowake’s CEO and founder Xiaoyun Wu said, “This financing will allow us to advance our pipeline and further improve our antibody platform, which will be critical in identifying and developing future products. This investment symbolizes a high level of confidence in our technology.”